Cantor Fitzgerald analyst Louis Chen reiterated an Overweight rating on Mesoblast Limited (NASDAQ: MESO).The analyst commented, "The Ryoncil launch is ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE